Zimmer Biomet Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Dell shares surge on record AI server bookings
- 'No panic anywhere' may be the problem, BofA strategists warn
- Kroger cuts same-store sales outlook, keeps earnings guidance
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Zimmer Biomet (ZBH) PT Raised to $153 at Needham & Company; Buy on Weakness
April 27, 2017 1:46 PM EDTNeedham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $151.00) while maintaining a Strong Buy rating but said disappointing Q1 results return the stock to a "show-me story" but they are recommending investors buy on today's weakness.
Analyst Mike... More
Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c; Narrows Outlook
April 27, 2017 7:37 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $2.13, $0.02 better than the analyst estimate of $2.11. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.
"Zimmer Biomet delivered first quarter revenue and adjusted earnings growth consistent with our... More
